## Discriminating LEMS from Paraneoplastic Cerebellar Degeneration ### Overview LEMS and PCD are both paraneoplastic neurological syndromes, but they affect different anatomical sites (neuromuscular junction vs. cerebellum) and have distinct electrophysiological signatures. ### Pathophysiology **Key Point:** LEMS is a disorder of the presynaptic neuromuscular junction (calcium channel dysfunction); PCD is a disorder of cerebellar Purkinje cells (antibody-mediated destruction). ### Comparison Table | Feature | LEMS | PCD | |---------|------|-----| | **Primary site affected** | Neuromuscular junction (presynaptic) | Cerebellum (Purkinje cells) | | **Clinical presentation** | Proximal weakness, hyporeflexia, autonomic dysfunction | Ataxia, nystagmus, dysarthria, cognitive decline | | **EMG finding** | **Incremental response to high-frequency RNS** | Normal or non-specific changes | | **Associated antibodies** | Anti-VGCC (P/Q-type, N-type) | Anti-Hu, Anti-Yo, Anti-CRMP5 | | **Associated malignancy** | SCLC (80–90%) | SCLC, ovarian, breast, lymphoma | | **Autonomic involvement** | Common (dry mouth, impotence, constipation) | Rare | | **Response to 3,4-DAP** | Dramatic improvement | No response | ### High-Yield Electrophysiology **High-Yield:** The **incremental response on high-frequency RNS** is PATHOGNOMONIC for LEMS and is the single most discriminating feature. In LEMS, repetitive stimulation at high frequency (20–50 Hz) causes progressive increase in compound muscle action potential (CMAP) amplitude by >100% — this is opposite to myasthenia gravis (decremental response). **Mnemonic:** **LEMS = Incremental (goes UP with high-frequency stim)** because calcium channels are partially blocked; repeated stimulation opens more channels. **Myasthenia = Decremental (goes DOWN)** because acetylcholine receptors are blocked. ### Why EMG Discriminates 1. **LEMS:** Presynaptic calcium channel blockade → reduced acetylcholine release at rest → weak CMAP initially. High-frequency stimulation → calcium accumulation → increased ACh release → CMAP amplitude increases (incremental response). 2. **PCD:** Cerebellar degeneration does NOT affect neuromuscular transmission → EMG is normal or shows only non-specific myopathic changes. No incremental or decremental response. ### Clinical Pearl **Clinical Pearl:** LEMS patients often improve dramatically with 3,4-diaminopyridine (3,4-DAP), which blocks potassium channels and prolongs action potentials, increasing calcium influx. PCD does not respond to 3,4-DAP because the problem is not at the neuromuscular junction. [cite:Harrison 21e Ch 381; Robbins 10e Ch 7]
Sign up free to access AI-powered MCQ practice with detailed explanations and adaptive learning.